Dr. Saab on Immunotherapy in MSI-H GI MalignanciesOncLiveTanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses immunotherapy in a patient with microsatellite instability-high (MSI-H) gastrointestinal malignancies. Patients whose disease… Continue reading
Scicasts (press release) (blog) |
Usher Syndrome: Gene Therapy Restores Hearing and Balance
Scicasts (press release) (blog) Paris, France (Scicasts) — Hearing loss, sometimes associated with other disorders such as balance defects, is the most common sensory deficit, affecting more than 280 million people worldwide, according to WHO. In France, one child in 700 is born … |
TechCrunch |
CRISPR breakthrough could drop miscarriage rates
TechCrunch Gene-editing technology CRISPR has revealed a clue in how human embryos begin to develop, possibly reducing the risk of miscarriage in those crucial first few weeks of pregnancy. CRISPR Cas9 can modify or snip out genetic defects thought to contribute … CRISPR Used for First Time to Study Gene Function in Human EmbryosGenetic Engineering & Biotechnology News CRISPR used to peer into human embryos’ first daysNature.com Researchers are Now Editing Genomes of Human EmbryosTIME Futurism –The Scientist –GenomeWeb –MedlinePlus all 112 news articles » |
TechCrunch |
CRISPR breakthrough could drop miscarriage rates
TechCrunch Gene-editing technology CRISPR has revealed a clue in how human embryos begin to develop, possibly reducing the risk of miscarriage in those crucial first few weeks of pregnancy. CRISPR Cas9 can modify or snip out genetic defects thought to contribute … CRISPR Used for First Time to Study Gene Function in Human EmbryosGenetic Engineering & Biotechnology News CRISPR used to peer into human embryos’ first daysNature.com Researchers are Now Editing Genomes of Human EmbryosTIME Futurism –The Scientist –MedlinePlus –NIH Stem Cell Information all 110 news articles » |
Immuno-Oncology News |
European Commission Approves Bavencio as First Immunotherapy for Adult Metastatic Merkel Cell Carcinoma
Immuno-Oncology News The European Commission (EC) has granted Bavencio (avelumab) marketing approval as the first immunotherapy to treat the aggressive skin cancer metastatic Merkel cell carcinoma in adults. The decision will allow an introduction of Bavencio — developed … Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU ApprovalNasdaq Merck, Pfizer get EC approval for skin cancer drug BavencioPharmaceutical Business Review |
Immuno-Oncology News |
European Commission Approves Bavencio as First Immunotherapy for Adult Metastatic Merkel Cell Carcinoma
Immuno-Oncology News The European Commission (EC) has granted Bavencio (avelumab) marketing approval as the first immunotherapy to treat the aggressive skin cancer metastatic Merkel cell carcinoma in adults. The decision will allow an introduction of Bavencio — developed … Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU ApprovalNasdaq Merck, Pfizer get EC approval for skin cancer drug BavencioPharmaceutical Business Review |
|
Signature Science Wins $2.9M IARPA Contract for Biological Threat Detection Computational Tools
GenomeWeb NEW YORK (GenomeWeb) – The Intelligence Advanced Research Projects Activity has awarded Signature Science a $2.9 million contract to develop new computational tools to screen DNA sequences to detect biological threats that may arise from synthetic … |
|
Signature Science Wins $2.9M IARPA Contract for Biological Threat Detection Computational Tools
GenomeWeb NEW YORK (GenomeWeb) – The Intelligence Advanced Research Projects Activity has awarded Signature Science a $2.9 million contract to develop new computational tools to screen DNA sequences to detect biological threats that may arise from synthetic … |